Attorney General Holder on J&J Risperdal Agreement
Nov. 4 (Bloomberg) -- U.S. Attorney General Eric Holder speaks at a news conference about the agreement between the Justice Department and Johnson & Johnson resolving criminal and civil probes into the marketing of the antipsychotic drug Risperdal and other medicines. The company and three of its subsidiaries will pay more than $2.2 billion to settle the investigations. Associate Attorney General Tony West, Assistant Attorney General Stuart Delery, Carmen Ortiz, U.S. attorney for the district of Massachusetts, and Zane Memeger, U.S. attorney for the eastern district of Pennsylania, also speak. (Source: Bloomberg)
Most Recent Videos
What Are the Chances of a Eurogroup Deal on Greece?
35:39 - Athens Chamber of Commerce President Constantine Michalos and Standard Chartered Bank Chief Economist Marios Maratheftis discuss the ongoing second review of Greece’s third bailout. They speak with Francine Lacqua on "Bloomberg Surveillance.” (Source: Bloomberg)